Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019

More evidence for inequitable COVID-19 outcomes in people with HIV

“…The contentious question as to whether tenofovir-disoproxil is truly protective against SARS-CoV-2 infection or worse clinical outcomes has yielded conflicting answers [11]. ATHENA joins the list of cohorts that do not show a protective effective of tenofovir-disoproxil in terms of COVID-19 outcomes, which may be due to better ability to adjust for confounders such as co-morbidities.…”